When Christophe Weber was appointed CEO of Takeda in 2014, he set out on a mission to transform the 240-year old Japanese pharmaceutical company into a major global player. Over the past six years ...
Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it's laser-focused on six pipeline assets that could each reel in ...
Hosted on MSN18d
Takeda CEO Weber on Drug Pipeline, Geopolitical RisksTakeda Pharmaceutical CEO Christophe Weber discusses the company's drug pipeline and current geopolitical risks with Katie Greifeld at the JPMorgan Health Care Conference in San Francisco.
Takeda (TAK) announced that its board of directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S.
5hon MSN
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Management View Christophe Weber, CEO, announced his retirement ...
A commitment to embracing AI and the changing digital world are key to success in legacy industries, Bank of America CEO Brian Moynihan and Takeda Pharmaceutical CEO Christophe Weber said. Why it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback